Stay updated on Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    New Revision: v3.6.6 was added, and the Plain Language Summary along with Revision: v3.6.5 were removed. This reflects an update to the page's versioning and the accessible content presented to readers.
    Difference
    0.0%
    Check dated 2026-09-01T20:43:06.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The page now includes an NIH grant/contract annotation for 2018 in the list of identifiers.
    Difference
    0.0%
    Check dated 2026-08-25T20:40:41.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.4 to v3.6.5, indicating a new build of the page. The provided changes do not specify any alterations to the page content.
    Difference
    0.0%
    Check dated 2026-08-11T22:56:06.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The revision label on the page was updated from v3.6.3 to v3.6.4, indicating an updated page revision tag rather than a change to the actual study information.
    Difference
    0.0%
    Check dated 2026-07-21T12:49:13.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Revision: v3.6.3 was added and Revision: v3.6.0 was removed, signaling a version update for the page. This represents an internal update to the page's versioning rather than a user-facing content change.
    Difference
    0.0%
    Check dated 2026-06-30T02:39:30.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    The page now includes a 'No longer looking for participants' notice indicating the study is not recruiting, and adds new sections 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study' to assist users. The header 'Intervention/Treatment' is standardized and the revision tag updates from v3.5.5 to v3.6.0.
    Difference
    0.2%
    Check dated 2026-06-15T21:54:52.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial page.